LENZ Therapeutics annual operating margin
2022
2025
LENZ Therapeutics Operating Margin Growth & History (LENZ)
LENZ Therapeutics's operating margin was −477.46% for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −477.46% | — |
| 2022 | 2022-12-31 | −704.26% | — |
LENZ Therapeutics quarterly operating margin
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −622.89% | −285.75 pp |
| Q1 2026 | 2026-03-31 | −2,321.67% | — |
| Q4 2025 | 2025-12-31 | −2,422.10% | — |
| Q3 2025 | 2025-09-30 | −151.10% | — |
| Q2 2025 | 2025-06-30 | −337.14% | — |
LENZ Therapeutics operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, LENZ Therapeutics's operating margin increased from −704.26% to −477.46%, a change of +226.80 percentage points. The latest reported quarter, Q2 2026, shows −622.89%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗